Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
06/2009
06/04/2009US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
06/04/2009US20090143357 Heteroaryl urea derivatives useful for inhibiting chk1
06/04/2009US20090140644 Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same
06/03/2009EP2064177A2 Protease inhibitors
06/03/2009CN101448795A Substituted pyrazinone derivatives for use as a medicine
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2009CA2394606C New modulators of dopamine neurotransmission
05/2009
05/28/2009WO2009067405A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor
05/28/2009US20090137805 N-phenyl-2-pyrimidine-amine derivatives
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137570 Inhibitors of cathepsin s
05/28/2009US20090137562 Substituted benzyl amine compounds
05/28/2009US20090137396 Piperazine Compounds with a Herbicidal Action
05/27/2009EP2061774A2 Arylpiperazine derivatives and uses thereof
05/27/2009EP2061764A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
05/27/2009EP2061762A2 Pyrazine compounds, their use and methods of preparation
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009EP0934287B1 Heterocyclic esters and amides
05/27/2009CN101440089A Compositions, methods and kits pertaining to luminescent compounds
05/27/2009CN101440067A Preparation of medicament intermediate 1-methyl-3-phenyl piperazine
05/27/2009CN100491375C Preparation method of ziprasidone
05/27/2009CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions
05/26/2009US7538216 Guanidino phenylalanin compounds used as urokinase inhibitors
05/26/2009US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4
05/26/2009US7538114 Glycine transporter-1 inhibitors
05/26/2009US7538110 e.g. 1-(8-(3-hydroxyphenyl)-7,8-dimethyl-hexahydro-1H-pyrido[1,2- alpha ]pyrazin-2(6H)-yl)-2-phenylethanone; analgesics; gastrointestinal dysfunction, post-surgical recovery; side effect reduction
05/26/2009US7538109 Quinoxalin-3-one derivatives as orexin receptor antagonists
05/26/2009CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
05/26/2009CA2344058C Diaminopropionic acid derivatives
05/26/2009CA2242879C Method for treating sexual dysfunctions
05/22/2009WO2009063180A1 Herbicidal compounds
05/22/2009WO2009039397A3 Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
05/22/2009CA2704930A1 Herbicidal compounds
05/21/2009US20090131661 Oxazolone Derivatives
05/21/2009US20090131453 Benzylpiperazine derivatives as motilin receptor antagonists
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/20/2009EP2059508A1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
05/20/2009EP2059239A2 Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
05/20/2009EP2059237A2 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
05/20/2009CN101433824A Method for extracting sulfabenzpyrazine from animal sample and special immune affinity sorbent thereof
05/20/2009CN100488923C Double-loop coil organic compounds and electric-field luminescent devices
05/19/2009US7534886 Has improved reactivity and gives a fluorine-containing elastomer or cured product having an excellent solvent resistance, chemical resistance, releasing property, and water repellency; prepared by reacting a diester compound with an amine compound
05/19/2009US7534794 Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
05/19/2009CA2192268C Amino alcohol derivative and method for preparing the same
05/14/2009US20090124630 N-[4-(2-methoxyphenyl)piperazin-1-yl)butyl]-3,4-dihydro-6-fluoro-2-naphthamide for treating neuropsychological disorder selected from Parkinson's disease, schizophrenia and depression; partial agonists or antagonists of the dopamine D3 receptor
05/14/2009US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors
05/14/2009US20090121617 Electronic devices made with electron transport and/or anti-quenching layers
05/14/2009US20090120800 Organic Silver Complexes, Their Preparation Methods and Their Methods for Forming Thin Layers
05/13/2009EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/13/2009CN101429167A Process for producing novel cadmium ion artificial antigen chelating agent
05/12/2009US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide
05/12/2009US7531543 Phenylpiperazine cycloalkanol derivatives and methods of their use
05/12/2009US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/12/2009US7531526 Boronic ester and acid compounds, synthesis and uses
05/12/2009CA2437785C Hiv inhibiting pyrazinone derivatives
05/12/2009CA2264005C Piperazino derivatives as neurokinin antagonists
05/07/2009WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
05/07/2009WO2009056070A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application
05/07/2009WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues
05/07/2009WO2009018065A3 Novel glucokinase activators and methods of using same
05/07/2009US20090118480 chitin/chitosan polymers with improved solubility characteristics; useful in pharmaceutical applications, in cosmetics, food science, water purification, pulp and paper industry, and in the textile industry
05/07/2009US20090118307 Aryl Sulfonamides
05/07/2009US20090118298 Octahydropentalene compounds as chemokine receptor antagonists
05/07/2009US20090118267 Indanes
05/07/2009US20090118257 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
05/07/2009US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses
05/07/2009US20090118169 Novel compounds and pharmaceutical use thereof
05/06/2009EP2054398A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer
05/06/2009EP2054395A2 Piperazine compounds with a herbicidal action
05/06/2009EP2054394A2 Piperazine compounds with a herbicidal action
05/06/2009EP1326865B1 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
05/06/2009CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient
05/06/2009CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin
05/06/2009CN100484925C Preparation process of intermediate 2-cyanpyrazine of pyrazinamide drug
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/05/2009CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands
05/05/2009CA2149298C Flk-1 is a receptor for vascular endothelial growth factor
04/2009
04/30/2009WO2009053763A1 New non-peptide derivatives as bradykinin b1 antagonists
04/30/2009WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
04/30/2009WO2009010429A3 Novel heterocyclyl compounds and their use as chemokine antagonists
04/30/2009WO2007016496A3 Dipiperazinyl ketones and related analogues
04/30/2009US20090111983 Cycloalkylcarbonylamino Acid Derivative and Process For Producing The Same
04/30/2009US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
04/30/2009US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity
04/30/2009CA2703471A1 Pyrazinyl amide t-type calcium channel antagonists
04/30/2009CA2703290A1 New non-peptide derivatives as bradykinin b1 antagonists
04/29/2009EP1828154B1 Phenyl-piperazin methanone derivatives
04/29/2009EP1771421B1 N-hydroxyamide derivatives and use thereof
04/29/2009EP1465585B1 Cosmetic compositions comprising a cyclodipeptide compound
04/29/2009CN101421230A Novel phenyl-propargylether derivatives
04/29/2009CN101417983A Method for synthesizing 2,5-diphenyl pyrazine
04/29/2009CN101417982A Synthesis of 4-ethyl-(2,3-dioxo piperazinyl)formyl chloride-1 and preparation of crystal thereof
04/29/2009CN101417981A 1,4-diethoxyl-2,6-diaryl piperazine hydrochloride and preparation method thereof
04/29/2009CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity
04/29/2009CN100483773C P type material and mikture used for electronic device
04/29/2009CN100482800C Steroselective preparation of cyclic L-amino acids
04/28/2009USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma
04/28/2009US7524957 Compounds effecting glucokinase
04/28/2009US7524956 Hemisynthetic method and new compounds
04/28/2009US7524874 Vanilloid receptor ligands and their use in treatments
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 187